Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3515LS3W
Performance in the last:
Follow this Portfolio
1D 0.0 %
1W -0.9 %
2W 2.3 %
1M 8.0 %
3M 5.5 %
6M 16.9 %
9M 4.7 %
1Y -67.1 %
Alpha
-81.6%
Beta
0.66
sharpe-R
-0.94
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
1.8
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2025-02-18 07:01:04
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -76.05%
Max. DrawDown Benchmark -8.41%

This Long-Short strategy aims to find promising assets to invest in for a maximum holding period of 3 Weeks in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 15.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

For Long-Short model portfolios, the short-selling costs (asset borrowing costs) are not taken into account. This assumption is likely unrealistic, and it is important to understand the short-selling process before employing this type of strategy.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
4

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 10% -9.54%
UTMD Utah Medical Products, Inc. Sell -5.16% 0.42%
AADI Aadi Bioscience, Inc. Sell -4.64% 10.38%
The percentage of cash held in the portfolio is: 99.8%
** The description of each asset is available Here

The latest 5 Compositions change

2025-02-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 10% -9.54%
UTMD Utah Medical Products, Inc. Sell -5.16% 0.42%
AADI Aadi Bioscience, Inc. Sell -4.64% 10.38%
The percentage of cash held in the portfolio is: 99.8%
New Assets Added
None
Assets Removed
Asset Action Perf %
HROW Buy All NA
Assets Rebalanced
None
2025-02-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 11.15% 1.73%
HROW Harrow Health, Inc. Sell -6.75% 3.96%
UTMD Utah Medical Products, Inc. Sell -5.01% 2.37%
AADI Aadi Bioscience, Inc. Sell -4.92% 4.15%
The percentage of cash held in the portfolio is: 105.54%
New Assets Added
None
Assets Removed
Asset Action Perf %
BLFS Sell All -7.77%
Assets Rebalanced
None
2025-02-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLFS BioLife Solutions, Inc. Buy 15.96% -7.46%
RGNX REGENXBIO Inc. Buy 11.42% 4.46%
HROW Harrow Health, Inc. Sell -6.74% 3.87%
UTMD Utah Medical Products, Inc. Sell -5.01% 2.3%
AADI Aadi Bioscience, Inc. Sell -5.02% 2.08%
The percentage of cash held in the portfolio is: 89.39%
New Assets Added
None
Assets Removed
Asset Action Perf %
HAE Buy All 14.33%
ORGO Sell All 6.61%
NUTX Sell All 54.16%
Assets Rebalanced
None
2025-02-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 11.75% 8.11%
NUTX Nutex Health Inc. Buy 15.55% 42.68%
BLFS BioLife Solutions, Inc. Buy 16.55% -5.58%
RGNX REGENXBIO Inc. Buy 11.61% 4.46%
HAE Haemonetics Corporation Sell -6.92% 3.11%
HROW Harrow Health, Inc. Sell -6.82% 4.34%
UTMD Utah Medical Products, Inc. Sell -5.1% 2.14%
AADI Aadi Bioscience, Inc. Sell -5.23% -0.35%
The percentage of cash held in the portfolio is: 68.6%
New Assets Added
None
Assets Removed
Asset Action Perf %
MDXG Sell All -3.17%
MD Sell All -0.14%
Assets Rebalanced
None
2025-02-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
MDXG MiMedx Group, Inc. Buy 11.52% -3.06%
MD Pediatrix Medical Group, Inc. Buy 11.51% -0.64%
ORGO Organogenesis Holdings Inc. Buy 11.58% 4.5%
NUTX Nutex Health Inc. Buy 14.05% 26.47%
BLFS BioLife Solutions, Inc. Buy 16.63% -6.96%
RGNX REGENXBIO Inc. Buy 11.83% 4.46%
HAE Haemonetics Corporation Sell -6.83% 6.27%
HROW Harrow Health, Inc. Sell -6.94% 4.52%
UTMD Utah Medical Products, Inc. Sell -5.19% 2.17%
AADI Aadi Bioscience, Inc. Sell -5.02% 5.54%
The percentage of cash held in the portfolio is: 46.85%
New Assets Added
None
Assets Removed
Asset Action Perf %
MDRX Buy All 47.11%
ACRS Sell All 0.4%
Assets Rebalanced
None
2025-02-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACRS Aclaris Therapeutics, Inc. Buy 11.44% -4%
MDXG MiMedx Group, Inc. Buy 11.63% -3.17%
MD Pediatrix Medical Group, Inc. Buy 11.63% -0.57%
ORGO Organogenesis Holdings Inc. Buy 11.46% 2.4%
NUTX Nutex Health Inc. Buy 14.29% 27.3%
BLFS BioLife Solutions, Inc. Buy 16.99% -5.94%
RGNX REGENXBIO Inc. Buy 11.09% -3.1%
HAE Haemonetics Corporation Sell -6.62% 10.04%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.55% 44.44%
HROW Harrow Health, Inc. Sell -6.79% 7.62%
UTMD Utah Medical Products, Inc. Sell -5.24% 2.27%
AADI Aadi Bioscience, Inc. Sell -5.09% 5.19%
The percentage of cash held in the portfolio is: 38.75%
New Assets Added
None
Assets Removed
Asset Action Perf %
INSM Sell All 12.98%
AXGN Sell All -1.81%
SIGA Sell All -9.55%
Assets Rebalanced
None
2025-02-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
INSM Insmed Incorporated Buy 11.54% 11.1%
AXGN AxoGen, Inc. Buy 12.87% -0.22%
ACRS Aclaris Therapeutics, Inc. Buy 11.69% -0.8%
MDXG MiMedx Group, Inc. Buy 11.71% -1.36%
MD Pediatrix Medical Group, Inc. Buy 11.55% -0.14%
ORGO Organogenesis Holdings Inc. Buy 12.23% 10.51%
NUTX Nutex Health Inc. Buy 13.72% 23.71%
SIGA SIGA Technologies, Inc. Buy 12.31% -6.42%
BLFS BioLife Solutions, Inc. Buy 17.22% -3.5%
RGNX REGENXBIO Inc. Buy 11.31% 0%
HAE Haemonetics Corporation Sell -6.83% 6.09%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.83% 39.33%
HROW Harrow Health, Inc. Sell -6.91% 4.86%
UTMD Utah Medical Products, Inc. Sell -5.29% 0.13%
AADI Aadi Bioscience, Inc. Sell -5.28% 0.35%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RGNX
Assets Removed
Asset Action Perf %
TGTX Sell All -0.69%
Assets Rebalanced
None
2025-01-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
INSM Insmed Incorporated Buy 11.77% 13.16%
AXGN AxoGen, Inc. Buy 12.95% 0.33%
ACRS Aclaris Therapeutics, Inc. Buy 11.13% -5.6%
MDXG MiMedx Group, Inc. Buy 12.19% 2.61%
MD Pediatrix Medical Group, Inc. Buy 11.73% 1.36%
ORGO Organogenesis Holdings Inc. Buy 12.64% 14.11%
NUTX Nutex Health Inc. Buy 12.91% 16.31%
SIGA SIGA Technologies, Inc. Buy 12.9% -2.03%
TGTX TG Therapeutics, Inc. Buy 11.92% 4.54%
BLFS BioLife Solutions, Inc. Buy 17.86% 0%
HAE Haemonetics Corporation Sell -6.76% 7.13%
MDRX Allscripts Healthcare Solutions, Inc. Sell -5.35% 15.44%
HROW Harrow Health, Inc. Sell -7.28% -0.19%
UTMD Utah Medical Products, Inc. Sell -5.31% 0%
AADI Aadi Bioscience, Inc. Sell -5.31% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • UTMD
  • AADI
  • BLFS
Assets Removed
Asset Action Perf %
ORMP Buy All 5.46%
AORT Sell All 3.27%
Assets Rebalanced
None
2025-01-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 11.72% 2.68%
INSM Insmed Incorporated Buy 12.01% 13.83%
AXGN AxoGen, Inc. Buy 13.21% 0.88%
ACRS Aclaris Therapeutics, Inc. Buy 11.44% -4.4%
MDXG MiMedx Group, Inc. Buy 12.38% 2.72%
MD Pediatrix Medical Group, Inc. Buy 12.13% 3.29%
ORGO Organogenesis Holdings Inc. Buy 12.01% 6.91%
NUTX Nutex Health Inc. Buy 12.52% 11.14%
SIGA SIGA Technologies, Inc. Buy 12.96% -2.97%
TGTX TG Therapeutics, Inc. Buy 12.12% 4.79%
ORMP Oramed Pharmaceuticals Inc. Sell -5.31% 5.46%
HAE Haemonetics Corporation Sell -6.92% 6.31%
MDRX Allscripts Healthcare Solutions, Inc. Sell -5.7% 11.11%
HROW Harrow Health, Inc. Sell -7.46% -1.27%
The percentage of cash held in the portfolio is: 2.9%
New Assets Added
None
Assets Removed
Asset Action Perf %
FATE Buy All 25.71%
Assets Rebalanced
Asset Action Weight
TGTX Sell -7.88%
AXGN Buy 0.48%
SIGA Buy 0.79%
2025-01-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 11.73% 1.36%
AXGN AxoGen, Inc. Buy 11.7% -1.75%
INSM Insmed Incorporated Buy 12.04% 12.62%
ACRS Aclaris Therapeutics, Inc. Buy 11.88% -2%
MD Pediatrix Medical Group, Inc. Buy 12.48% 4.86%
MDXG MiMedx Group, Inc. Buy 12.06% -1.25%
ORGO Organogenesis Holdings Inc. Buy 12.79% 12.31%
NUTX Nutex Health Inc. Buy 12% 5.09%
SIGA SIGA Technologies, Inc. Buy 11.97% -0.78%
TGTX TG Therapeutics, Inc. Buy 19.35% 0%
FATE Fate Therapeutics, Inc. Sell -4.48% 21.71%
ORMP Oramed Pharmaceuticals Inc. Sell -5.36% 5.88%
HAE Haemonetics Corporation Sell -7.26% 3.05%
MDRX Allscripts Healthcare Solutions, Inc. Sell -5.44% 16.33%
HROW Harrow Health, Inc. Sell -7.47% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HROW
  • TGTX
Assets Removed
Asset Action Perf %
ESPR Sell All -14.96%
Assets Rebalanced
None
2025-01-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 11.6% 1.42%
ESPR Esperion Therapeutics, Inc. Buy 12.37% -10.26%
AXGN AxoGen, Inc. Buy 11.7% -0.6%
INSM Insmed Incorporated Buy 12.04% 13.85%
ACRS Aclaris Therapeutics, Inc. Buy 12.04% 0.4%
MD Pediatrix Medical Group, Inc. Buy 12.04% 2.29%
MDXG MiMedx Group, Inc. Buy 12.04% -0.34%
ORGO Organogenesis Holdings Inc. Buy 12.04% 6.91%
NUTX Nutex Health Inc. Buy 12.47% 10.49%
SIGA SIGA Technologies, Inc. Buy 12.04% 0.94%
FATE Fate Therapeutics, Inc. Sell -4.3% 24%
ORMP Oramed Pharmaceuticals Inc. Sell -5.37% 4.62%
HAE Haemonetics Corporation Sell -7.13% 3.69%
MDRX Allscripts Healthcare Solutions, Inc. Sell -5.57% 13.33%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
TGTX Buy All -11.64%
Assets Rebalanced
Asset Action Weight
AXGN Sell -1.98%
ACRS Sell -1.81%
INSM Sell -3.64%
ORGO Sell -23.86%
NUTX Buy 1.71%
SIGA Buy 4.12%
MD Buy 9.28%
MDXG Buy 9.35%
2025-01-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 11.71% 1.82%
ESPR Esperion Therapeutics, Inc. Buy 13.02% -5.98%
AXGN AxoGen, Inc. Buy 14.33% 3.51%
INSM Insmed Incorporated Buy 15.75% 13.81%
ACRS Aclaris Therapeutics, Inc. Buy 14.42% 4%
MD Pediatrix Medical Group, Inc. Buy 2.72% 0.5%
MDXG MiMedx Group, Inc. Buy 2.76% 1.93%
ORGO Organogenesis Holdings Inc. Buy 35.47% 5.11%
NUTX Nutex Health Inc. Buy 9.3% -1.01%
SIGA SIGA Technologies, Inc. Buy 7.88% 0%
TGTX TG Therapeutics, Inc. Sell -5.99% -4.07%
FATE Fate Therapeutics, Inc. Sell -4.35% 23.43%
ORMP Oramed Pharmaceuticals Inc. Sell -5.49% 2.94%
HAE Haemonetics Corporation Sell -7.42% 0.24%
MDRX Allscripts Healthcare Solutions, Inc. Sell -6.12% 5.33%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • SIGA
Assets Removed
Asset Action Perf %
BLUE Sell All -20.97%
Assets Rebalanced
None
2025-01-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLUE bluebird bio, Inc. Buy 8.2% -17.94%
AORT Artivion, Inc. Buy 12.03% 4.5%
ESPR Esperion Therapeutics, Inc. Buy 12.74% -8.12%
AXGN AxoGen, Inc. Buy 14.41% 3.95%
INSM Insmed Incorporated Buy 15.43% 11.34%
ACRS Aclaris Therapeutics, Inc. Buy 14.44% 4%
MD Pediatrix Medical Group, Inc. Buy 2.71% 0%
MDXG MiMedx Group, Inc. Buy 2.81% 3.63%
ORGO Organogenesis Holdings Inc. Buy 35.82% 6.01%
NUTX Nutex Health Inc. Buy 9.41% 0%
TGTX TG Therapeutics, Inc. Sell -6.15% -6.64%
FATE Fate Therapeutics, Inc. Sell -4.29% 24.57%
ORMP Oramed Pharmaceuticals Inc. Sell -5.47% 3.36%
HAE Haemonetics Corporation Sell -7.62% -2.33%
MDRX Allscripts Healthcare Solutions, Inc. Sell -6.47% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MDRX
  • NUTX
Assets Removed
Asset Action Perf %
APLS Buy All -9.8%
TNDM Sell All -5.5%
Assets Rebalanced
None
2025-01-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLUE bluebird bio, Inc. Buy 8.49% -16.73%
TNDM Tandem Diabetes Care, Inc. Buy 10.24% 0.47%
AORT Artivion, Inc. Buy 12.14% 3.34%
ESPR Esperion Therapeutics, Inc. Buy 13.67% -3.42%
AXGN AxoGen, Inc. Buy 14.28% 0.99%
INSM Insmed Incorporated Buy 14.92% 5.54%
ACRS Aclaris Therapeutics, Inc. Buy 14.22% 0.4%
MD Pediatrix Medical Group, Inc. Buy 2.72% -1.64%
MDXG MiMedx Group, Inc. Buy 2.85% 2.95%
ORGO Organogenesis Holdings Inc. Buy 34.48% 0%
TGTX TG Therapeutics, Inc. Sell -6.12% -4.07%
FATE Fate Therapeutics, Inc. Sell -4.15% 28.57%
ORMP Oramed Pharmaceuticals Inc. Sell -5.63% 2.52%
APLS Apellis Pharmaceuticals, Inc. Sell -6.51% -8.35%
HAE Haemonetics Corporation Sell -7.6% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HAE
  • ORGO
Assets Removed
Asset Action Perf %
NUTX Buy All -22.6%
MDRX Sell All -6.56%
Assets Rebalanced
None
2025-01-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLUE bluebird bio, Inc. Buy 8.86% -16.43%
TNDM Tandem Diabetes Care, Inc. Buy 10.21% -3.76%
MDRX Allscripts Healthcare Solutions, Inc. Buy 10.85% -4.51%
AORT Artivion, Inc. Buy 12.15% -0.56%
ESPR Esperion Therapeutics, Inc. Buy 13.91% -5.56%
AXGN AxoGen, Inc. Buy 15.1% 2.63%
INSM Insmed Incorporated Buy 14.99% 1.84%
ACRS Aclaris Therapeutics, Inc. Buy 14.8% 0.4%
MD Pediatrix Medical Group, Inc. Buy 2.88% 0%
MDXG MiMedx Group, Inc. Buy 2.88% 0%
TGTX TG Therapeutics, Inc. Sell -6.59% -7.79%
FATE Fate Therapeutics, Inc. Sell -4.56% 24.57%
ORMP Oramed Pharmaceuticals Inc. Sell -5.91% 1.68%
NUTX Nutex Health Inc. Sell 15.05% -5.86%
APLS Apellis Pharmaceuticals, Inc. Sell -6.61% -5.79%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MD
  • MDXG
Assets Removed
Asset Action Perf %
ARDX Sell All 0.19%
Assets Rebalanced
None
2025-01-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLUE bluebird bio, Inc. Buy 8.61% -19.25%
TNDM Tandem Diabetes Care, Inc. Buy 10.21% -4.19%
MDRX Allscripts Healthcare Solutions, Inc. Buy 10.66% -6.67%
AORT Artivion, Inc. Buy 12.06% -1.82%
ARDX Ardelyx, Inc. Buy 12.93% 5.24%
ESPR Esperion Therapeutics, Inc. Buy 14.17% -4.27%
AXGN AxoGen, Inc. Buy 14.78% -0.05%
INSM Insmed Incorporated Buy 14.65% -0.93%
ACRS Aclaris Therapeutics, Inc. Buy 14.81% 0%
NUTX Nutex Health Inc. Sell 14.81% -3.63%
TGTX TG Therapeutics, Inc. Sell -6.53% -6.21%
FATE Fate Therapeutics, Inc. Sell -4.34% 28.57%
ORMP Oramed Pharmaceuticals Inc. Sell -5.99% 0.84%
APLS Apellis Pharmaceuticals, Inc. Sell -6.34% -0.91%
The percentage of cash held in the portfolio is: -4.51%
New Assets Added
  • NUTX
  • ACRS
Assets Removed
None
Assets Rebalanced
None
2025-01-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 10.1% -3.07%
BLUE bluebird bio, Inc. Buy 8.92% -14.42%
MDRX Allscripts Healthcare Solutions, Inc. Buy 10.88% -2.56%
AORT Artivion, Inc. Buy 11.65% -2.94%
ARDX Ardelyx, Inc. Buy 13.22% 10.11%
ESPR Esperion Therapeutics, Inc. Buy 14.09% -2.56%
AXGN AxoGen, Inc. Buy 14.46% 0%
INSM Insmed Incorporated Buy 14.46% 0%
TGTX TG Therapeutics, Inc. Sell -5.94% 1.18%
FATE Fate Therapeutics, Inc. Sell -4.37% 26.29%
ORMP Oramed Pharmaceuticals Inc. Sell -5.86% 0.84%
NUTX Nutex Health Inc. Sell -6.12% 0.39%
APLS Apellis Pharmaceuticals, Inc. Sell -6.4% -4.19%
The percentage of cash held in the portfolio is: 30.91%
New Assets Added
  • AXGN
  • INSM
Assets Removed
None
Assets Rebalanced
None
2025-01-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 10.25% -3.63%
BLUE bluebird bio, Inc. Buy 9.07% -14.72%
MDRX Allscripts Healthcare Solutions, Inc. Buy 11.11% -2.46%
AORT Artivion, Inc. Buy 12.11% -1.16%
ARDX Ardelyx, Inc. Buy 11.64% -5.06%
ESPR Esperion Therapeutics, Inc. Buy 14.76% 0%
TGTX TG Therapeutics, Inc. Sell -6.33% -3.14%
FATE Fate Therapeutics, Inc. Sell -5.09% 16%
ORMP Oramed Pharmaceuticals Inc. Sell -6.05% -0.42%
NUTX Nutex Health Inc. Sell -6.27% 0%
APLS Apellis Pharmaceuticals, Inc. Sell -6.27% 0%
The percentage of cash held in the portfolio is: 61.06%
New Assets Added
  • NUTX
  • APLS
  • ESPR
Assets Removed
None
Assets Rebalanced
None
2025-01-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 10.61% 0.36%
BLUE bluebird bio, Inc. Buy 9.02% -14.72%
MDRX Allscripts Healthcare Solutions, Inc. Buy 11.05% -2.46%
AORT Artivion, Inc. Buy 12.19% 0%
ARDX Ardelyx, Inc. Buy 12.19% 0%
TGTX TG Therapeutics, Inc. Sell -6.27% -2.75%
FATE Fate Therapeutics, Inc. Sell -5.75% 4.57%
ORMP Oramed Pharmaceuticals Inc. Sell -5.99% 0%
The percentage of cash held in the portfolio is: 62.95%
New Assets Added
  • ORMP
  • AORT
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2025-01-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 10.42% -0.82%
BLUE bluebird bio, Inc. Buy 9.55% -9.07%
MDRX Allscripts Healthcare Solutions, Inc. Buy 11.26% 0%
TGTX TG Therapeutics, Inc. Sell -6.06% 0%
FATE Fate Therapeutics, Inc. Sell -5.98% 0%
The percentage of cash held in the portfolio is: 80.81%
New Assets Added
  • FATE
  • MDRX
Assets Removed
None
Assets Rebalanced
None
2025-01-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 10.4% 0%
BLUE bluebird bio, Inc. Buy 10.4% 0%
TGTX TG Therapeutics, Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 85.2%
New Assets Added
  • TGTX
  • TNDM
  • BLUE
Assets Removed
None
Assets Rebalanced
None
2024-12-26 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
PCRX Sell All NA
Assets Rebalanced
None
2024-12-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
PCRX Pacira BioSciences, Inc. Buy 13.2% 1.99%
The percentage of cash held in the portfolio is: 86.8%
New Assets Added
None
Assets Removed
Asset Action Perf %
CUTR Buy All 19.51%
NKTR Buy All 14.95%
FATE Buy All 36.88%
Assets Rebalanced
None
2024-12-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
PCRX Pacira BioSciences, Inc. Buy 13% -0.58%
CUTR Cutera, Inc. Sell -5.83% 12.2%
NKTR Nektar Therapeutics Sell -5.77% 13.08%
FATE Fate Therapeutics, Inc. Sell -4.24% 36.12%
The percentage of cash held in the portfolio is: 102.85%
New Assets Added
None
Assets Removed
Asset Action Perf %
IBRX Buy All 48.02%
Assets Rebalanced
None
2024-12-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
PCRX Pacira BioSciences, Inc. Buy 13.66% 3.88%
IBRX ImmunityBio, Inc. Sell -3.58% 43.85%
CUTR Cutera, Inc. Sell -5.7% 14.63%
NKTR Nektar Therapeutics Sell -6.37% 4.67%
FATE Fate Therapeutics, Inc. Sell -4.78% 28.52%
The percentage of cash held in the portfolio is: 106.77%
New Assets Added
None
Assets Removed
Asset Action Perf %
APLS Sell All 5.82%
MGNX Sell All -1.76%
Assets Rebalanced
None
2024-12-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 13.02% 4.2%
MGNX MacroGenics, Inc. Buy 12.53% 0.29%
PCRX Pacira BioSciences, Inc. Buy 14.14% 6.5%
IBRX ImmunityBio, Inc. Sell -4.03% 37.5%
CUTR Cutera, Inc. Sell -5.92% 12.2%
NKTR Nektar Therapeutics Sell -6.43% 4.67%
FATE Fate Therapeutics, Inc. Sell -5.59% 17.11%
The percentage of cash held in the portfolio is: 82.28%
New Assets Added
None
Assets Removed
Asset Action Perf %
ESPR Sell All -13.23%
Assets Rebalanced
None
2024-12-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 13.4% 7.32%
MGNX MacroGenics, Inc. Buy 12.78% 2.35%
ESPR Esperion Therapeutics, Inc. Buy 12.94% 23.55%
PCRX Pacira BioSciences, Inc. Buy 13.27% 0%
IBRX ImmunityBio, Inc. Sell -6.13% 4.76%
CUTR Cutera, Inc. Sell -6.08% 9.76%
NKTR Nektar Therapeutics Sell -6.36% 5.61%
FATE Fate Therapeutics, Inc. Sell -6.97% -3.42%
The percentage of cash held in the portfolio is: 73.15%
New Assets Added
None
Assets Removed
Asset Action Perf %
PACB Buy All -23.86%
RVNC Sell All -27.34%
Assets Rebalanced
None
2024-12-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 12.75% 4.6%
MGNX MacroGenics, Inc. Buy 12.51% 2.65%
ESPR Esperion Therapeutics, Inc. Buy 12.07% 18.06%
RVNC Revance Therapeutics, Inc. Buy 12.95% 0%
PCRX Pacira BioSciences, Inc. Buy 12.95% 0%
PACB Pacific Biosciences of California, Inc. Sell -5.45% -18.18%
IBRX ImmunityBio, Inc. Sell -5.91% 5.95%
CUTR Cutera, Inc. Sell -6.9% -4.88%
NKTR Nektar Therapeutics Sell -6.27% 4.67%
FATE Fate Therapeutics, Inc. Sell -6.4% 2.66%
The percentage of cash held in the portfolio is: 67.7%
New Assets Added
  • RVNC
  • PCRX
Assets Removed
Asset Action Perf %
ARWR Sell All -11.63%
Assets Rebalanced
None
2024-12-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 12.84% 6.13%
MGNX MacroGenics, Inc. Buy 12.24% 1.18%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.77% -0.31%
ESPR Esperion Therapeutics, Inc. Buy 10.64% 4.84%
PACB Pacific Biosciences of California, Inc. Sell -4.76% -3.98%
IBRX ImmunityBio, Inc. Sell -5.65% 9.52%
CUTR Cutera, Inc. Sell -6.53% 0%
NKTR Nektar Therapeutics Sell -6.53% 0%
FATE Fate Therapeutics, Inc. Sell -6.53% 0%
The percentage of cash held in the portfolio is: 82.5%
New Assets Added
  • CUTR
  • NKTR
  • FATE
Assets Removed
None
Assets Rebalanced
None
2024-12-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 13.13% 8.55%
MGNX MacroGenics, Inc. Buy 13.13% 8.53%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.89% 0.73%
ESPR Esperion Therapeutics, Inc. Buy 10.15% 0%
PACB Pacific Biosciences of California, Inc. Sell -5.01% -9.66%
IBRX ImmunityBio, Inc. Sell -6.15% 1.39%
The percentage of cash held in the portfolio is: 62.87%
New Assets Added
  • ESPR
Assets Removed
Asset Action Perf %
FATE Sell All -6.62%
Assets Rebalanced
None
2024-12-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 12.62% 3.98%
MGNX MacroGenics, Inc. Buy 12.81% 5.59%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.78% -0.46%
FATE Fate Therapeutics, Inc. Buy 11.84% 0%
PACB Pacific Biosciences of California, Inc. Sell -4.98% -8.52%
IBRX ImmunityBio, Inc. Sell -6.26% 0%
The percentage of cash held in the portfolio is: 62.19%
New Assets Added
  • IBRX
Assets Removed
Asset Action Perf %
CUTR Buy All -25.64%
Assets Rebalanced
None
2024-11-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 12.54% 4.63%
MGNX MacroGenics, Inc. Buy 12.83% 7.06%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.69% 0%
FATE Fate Therapeutics, Inc. Buy 11.69% 0%
CUTR Cutera, Inc. Sell -7.65% -17.95%
PACB Pacific Biosciences of California, Inc. Sell -4.53% 0%
The percentage of cash held in the portfolio is: 63.42%
New Assets Added
None
Assets Removed
Asset Action Perf %
AMPH Buy All NA
Assets Rebalanced
None
2024-11-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 12.54% 4.63%
MGNX MacroGenics, Inc. Buy 12.83% 7.06%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.69% 0%
FATE Fate Therapeutics, Inc. Buy 11.69% 0%
AMPH Amphastar Pharmaceuticals, Inc. Sell -8.75% 1.91%
CUTR Cutera, Inc. Sell -7.65% -17.95%
PACB Pacific Biosciences of California, Inc. Sell -4.53% 0%
The percentage of cash held in the portfolio is: 72.17%
New Assets Added
  • PACB
  • ARWR
  • FATE
Assets Removed
Asset Action Perf %
AZTA Buy All -10.51%
Assets Rebalanced
None
2024-11-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 11.97% 0%
MGNX MacroGenics, Inc. Buy 11.97% 0%
AMPH Amphastar Pharmaceuticals, Inc. Sell -8.55% 4.06%
CUTR Cutera, Inc. Sell -6.48% 0%
AZTA Azenta, Inc. Sell -6.67% -7.34%
The percentage of cash held in the portfolio is: 97.76%
New Assets Added
  • APLS
  • MGNX
Assets Removed
None
Assets Rebalanced
None
2024-11-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
AMPH Amphastar Pharmaceuticals, Inc. Sell -8.55% 3.15%
CUTR Cutera, Inc. Sell -5.43% 15.38%
AZTA Azenta, Inc. Sell -6.59% -6.92%
The percentage of cash held in the portfolio is: 120.56%
New Assets Added
None
Assets Removed
Asset Action Perf %
CORT Sell All 17.92%
Assets Rebalanced
None
2024-11-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
CORT Corcept Therapeutics Incorporated Buy 12.83% 12.05%
AMPH Amphastar Pharmaceuticals, Inc. Sell -8.44% 4.34%
CUTR Cutera, Inc. Sell -4.93% 23.08%
AZTA Azenta, Inc. Sell -6.45% -4.74%
The percentage of cash held in the portfolio is: 106.99%
New Assets Added
None
Assets Removed
Asset Action Perf %
IRTC Sell All -9.45%
Assets Rebalanced
None
2024-11-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
CORT Corcept Therapeutics Incorporated Buy 12.37% 8.49%
IRTC iRhythm Technologies, Inc. Buy 10.56% -7.33%
AMPH Amphastar Pharmaceuticals, Inc. Sell -8.31% 5.36%
CUTR Cutera, Inc. Sell -4.91% 23.08%
AZTA Azenta, Inc. Sell -5.88% 4.03%
The percentage of cash held in the portfolio is: 96.17%
New Assets Added
None
Assets Removed
Asset Action Perf %
NEOG Sell All 5.23%
MGNX Sell All -10.08%
Assets Rebalanced
None
2024-11-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
NEOG Neogen Corporation Buy 12.04% 6%
MGNX MacroGenics, Inc. Buy 9.96% -9.3%
CORT Corcept Therapeutics Incorporated Buy 11.97% 5.11%
IRTC iRhythm Technologies, Inc. Buy 10.75% -5.62%
AMPH Amphastar Pharmaceuticals, Inc. Sell -8.4% 4.19%
CUTR Cutera, Inc. Sell -4.74% 25.64%
AZTA Azenta, Inc. Sell -5.8% 5.3%
The percentage of cash held in the portfolio is: 74.22%
New Assets Added
None
Assets Removed
Asset Action Perf %
CHRS Buy All -8.17%
VERU Buy All 29.76%
HCSG Sell All 2.56%
Assets Rebalanced
None
2024-11-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 14.6% 5.39%
NEOG Neogen Corporation Buy 11.56% 1.81%
MGNX MacroGenics, Inc. Buy 10.13% -7.75%
CORT Corcept Therapeutics Incorporated Buy 11.78% 3.54%
IRTC iRhythm Technologies, Inc. Buy 11.24% -1.22%
CHRS Coherus BioSciences, Inc. Sell -6.12% -3.05%
VERU Veru Inc. Sell -4.1% 30.95%
AMPH Amphastar Pharmaceuticals, Inc. Sell -8.48% 3.21%
CUTR Cutera, Inc. Sell -5.23% 17.95%
AZTA Azenta, Inc. Sell -5.96% 2.63%
The percentage of cash held in the portfolio is: 70.58%
New Assets Added
None
Assets Removed
Asset Action Perf %
RGEN Sell All -17.11%
Assets Rebalanced
None
2024-11-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 14.66% 8.95%
NEOG Neogen Corporation Buy 11.26% 2.09%
MGNX MacroGenics, Inc. Buy 10.49% -1.55%
CORT Corcept Therapeutics Incorporated Buy 12.09% 9.45%
IRTC iRhythm Technologies, Inc. Buy 11.32% 2.46%
RGEN Repligen Corporation Buy 13.2% -5.34%
CHRS Coherus BioSciences, Inc. Sell -6.18% -7.06%
VERU Veru Inc. Sell -4.33% 25%
AMPH Amphastar Pharmaceuticals, Inc. Sell -8.32% 2.23%
CUTR Cutera, Inc. Sell -5.24% 15.38%
AZTA Azenta, Inc. Sell -5.94% 0%
The percentage of cash held in the portfolio is: 56.97%
New Assets Added
  • AZTA
Assets Removed
Asset Action Perf %
COLL Buy All 11.77%
SAGE Sell All -15.03%
ALT Sell All -10.91%
Assets Rebalanced
None
2024-11-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 14.38% 11.32%
NEOG Neogen Corporation Buy 11.21% 5.86%
MGNX MacroGenics, Inc. Buy 9.97% -2.58%
CORT Corcept Therapeutics Incorporated Buy 11.96% 12.76%
IRTC iRhythm Technologies, Inc. Buy 11.35% 6.99%
SAGE Sage Therapeutics, Inc. Buy 13.63% -9.34%
ALT Altimmune, Inc. Buy 13.26% 0.32%
RGEN Repligen Corporation Buy 13.39% 0%
COLL Collegium Pharmaceutical, Inc. Sell -4.32% 12.04%
CHRS Coherus BioSciences, Inc. Sell -5.98% -7.89%
VERU Veru Inc. Sell -4.09% 26.19%
AMPH Amphastar Pharmaceuticals, Inc. Sell -8.06% 1.32%
CUTR Cutera, Inc. Sell -5.48% 7.69%
The percentage of cash held in the portfolio is: 28.77%
New Assets Added
  • RGEN
Assets Removed
Asset Action Perf %
CARA Sell All -6.09%
CDMO Sell All 17.76%
Assets Rebalanced
None
2024-11-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDMO Avid Bioservices, Inc. Buy 12.76% 18.05%
HCSG Healthcare Services Group, Inc. Buy 14.58% 13.61%
NEOG Neogen Corporation Buy 11.25% 6.97%
MGNX MacroGenics, Inc. Buy 10.77% 5.94%
CORT Corcept Therapeutics Incorporated Buy 12.17% 15.44%
IRTC iRhythm Technologies, Inc. Buy 11.28% 7.07%
CARA Cara Therapeutics, Inc. Buy 14.76% -1.16%
SAGE Sage Therapeutics, Inc. Buy 13.54% -9.34%
ALT Altimmune, Inc. Buy 13.13% 0%
COLL Collegium Pharmaceutical, Inc. Sell -4.46% 8.45%
CHRS Coherus BioSciences, Inc. Sell -6.28% -14.13%
VERU Veru Inc. Sell -4.32% 21.43%
AMPH Amphastar Pharmaceuticals, Inc. Sell -8.4% -3.51%
CUTR Cutera, Inc. Sell -5.9% 0%
The percentage of cash held in the portfolio is: 15.13%
New Assets Added
  • ALT
Assets Removed
Asset Action Perf %
IOVA Sell All -12.15%
NUTX Sell All 51.33%
Assets Rebalanced
None
2024-11-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 13.88% 27.16%
CDMO Avid Bioservices, Inc. Buy 12.8% 18.34%
HCSG Healthcare Services Group, Inc. Buy 13.93% 8.4%
IOVA Iovance Biotherapeutics, Inc. Buy 10% -3.99%
NEOG Neogen Corporation Buy 11.91% 13.18%
MGNX MacroGenics, Inc. Buy 11.44% 12.4%
CORT Corcept Therapeutics Incorporated Buy 12.56% 19.06%
IRTC iRhythm Technologies, Inc. Buy 11.2% 6.19%
CARA Cara Therapeutics, Inc. Buy 14.73% -1.45%
SAGE Sage Therapeutics, Inc. Buy 14.93% -0.16%
COLL Collegium Pharmaceutical, Inc. Sell -4.57% 6.27%
CHRS Coherus BioSciences, Inc. Sell -6.22% -12.88%
VERU Veru Inc. Sell -4.79% 13.1%
AMPH Amphastar Pharmaceuticals, Inc. Sell -8.52% -4.82%
CUTR Cutera, Inc. Sell -5.91% 0%
The percentage of cash held in the portfolio is: 2.61%
New Assets Added
  • CUTR
Assets Removed
Asset Action Perf %
EVH Buy All 42.39%
Assets Rebalanced
Asset Action Weight
HCSG Buy 1.34%
2024-11-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 13.06% 16.4%
CDMO Avid Bioservices, Inc. Buy 13.13% 18.15%
HCSG Healthcare Services Group, Inc. Buy 11.65% 7.31%
IOVA Iovance Biotherapeutics, Inc. Buy 11.92% 11.33%
NEOG Neogen Corporation Buy 11.9% 10.04%
MGNX MacroGenics, Inc. Buy 12.05% 15.25%
IRTC iRhythm Technologies, Inc. Buy 11.81% 8.99%
CORT Corcept Therapeutics Incorporated Buy 11.76% 8.47%
CARA Cara Therapeutics, Inc. Buy 15.36% 0%
SAGE Sage Therapeutics, Inc. Buy 15.36% 0%
EVH Evolent Health, Inc. Sell -5.24% -5.95%
COLL Collegium Pharmaceutical, Inc. Sell -5.07% -1.17%
CHRS Coherus BioSciences, Inc. Sell -6.43% -13.57%
VERU Veru Inc. Sell -4.92% 13.1%
AMPH Amphastar Pharmaceuticals, Inc. Sell -8.35% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • AMPH
  • CARA
  • SAGE
Assets Removed
Asset Action Perf %
NVRO Sell All -1.11%
VREX Sell All 17.93%
Assets Rebalanced
None
2024-11-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 11.92% 19.42%
NUTX Nutex Health Inc. Buy 12.43% 9.47%
CDMO Avid Bioservices, Inc. Buy 11.92% 5.98%
HCSG Healthcare Services Group, Inc. Buy 11.92% 8.49%
IOVA Iovance Biotherapeutics, Inc. Buy 11.92% 10.06%
NEOG Neogen Corporation Buy 11.92% 8.93%
NVRO Nevro Corp. Buy 11.79% 7.04%
MGNX MacroGenics, Inc. Buy 11.46% 8.27%
IRTC iRhythm Technologies, Inc. Buy 12.06% 9.9%
CORT Corcept Therapeutics Incorporated Buy 11.88% 8.33%
EVH Evolent Health, Inc. Sell -5.34% -6.81%
COLL Collegium Pharmaceutical, Inc. Sell -5.1% -0.55%
CHRS Coherus BioSciences, Inc. Sell -5.74% -0.28%
VERU Veru Inc. Sell -5.05% 11.9%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
SMTI Buy All -11.47%
Assets Rebalanced
Asset Action Weight
NVRO Sell -1.25%
HCSG Sell -11.43%
IOVA Sell -11.76%
NUTX Buy 1.07%
VREX Buy 2.76%
NEOG Buy 4.72%
CDMO Buy 9.55%
2024-11-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 9.21% 9.5%
NUTX Nutex Health Inc. Buy 10.1% -7.17%
CDMO Avid Bioservices, Inc. Buy 2.45% -0.19%
HCSG Healthcare Services Group, Inc. Buy 24.08% 2.01%
IOVA Iovance Biotherapeutics, Inc. Buy 24.48% 3.72%
NEOG Neogen Corporation Buy 7.3% 0.63%
NVRO Nevro Corp. Buy 13.24% -0.93%
MGNX MacroGenics, Inc. Buy 11.1% -4.39%
IRTC iRhythm Technologies, Inc. Buy 12.03% 0%
CORT Corcept Therapeutics Incorporated Buy 12.03% 0%
EVH Evolent Health, Inc. Sell -5.53% -0.73%
SMTI Sanara MedTech Inc. Sell -5.9% -6.02%
COLL Collegium Pharmaceutical, Inc. Sell -5.31% 4.63%
CHRS Coherus BioSciences, Inc. Sell -5.83% 7.2%
VERU Veru Inc. Sell -5.46% 13.1%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • IRTC
  • CORT
Assets Removed
Asset Action Perf %
ARWR Sell All 3.62%
VCEL Sell All 5.42%
Assets Rebalanced
None
2024-11-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.74% 0.67%
VCEL Vericel Corporation Buy 12.18% 4.51%
VREX Varex Imaging Corporation Buy 9.28% 9.09%
NUTX Nutex Health Inc. Buy 10.02% -8.94%
CDMO Avid Bioservices, Inc. Buy 2.46% -0.87%
HCSG Healthcare Services Group, Inc. Buy 24.31% 1.83%
IOVA Iovance Biotherapeutics, Inc. Buy 24.23% 1.45%
NEOG Neogen Corporation Buy 7.39% 0.7%
NVRO Nevro Corp. Buy 13.84% 2.41%
MGNX MacroGenics, Inc. Buy 11.74% 0%
EVH Evolent Health, Inc. Sell -5.61% -1.16%
SMTI Sanara MedTech Inc. Sell -5.98% -6.21%
COLL Collegium Pharmaceutical, Inc. Sell -5.49% 2.48%
CHRS Coherus BioSciences, Inc. Sell -6.36% -0.14%
VERU Veru Inc. Sell -5.75% 9.52%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MGNX
Assets Removed
Asset Action Perf %
ARDX Sell All 0.83%
Assets Rebalanced
None
2024-10-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 11.45% -2.48%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.95% 1.81%
VCEL Vericel Corporation Buy 12.7% 8.2%
VREX Varex Imaging Corporation Buy 9.45% 10.33%
NUTX Nutex Health Inc. Buy 10.51% -5.16%
CDMO Avid Bioservices, Inc. Buy 2.45% -2.03%
HCSG Healthcare Services Group, Inc. Buy 24.26% 0.91%
IOVA Iovance Biotherapeutics, Inc. Buy 24.06% 0.09%
NEOG Neogen Corporation Buy 7.51% 1.6%
NVRO Nevro Corp. Buy 13.61% 0%
EVH Evolent Health, Inc. Sell -5.82% -4.1%
SMTI Sanara MedTech Inc. Sell -5.88% -3.8%
COLL Collegium Pharmaceutical, Inc. Sell -5.73% -1.05%
CHRS Coherus BioSciences, Inc. Sell -6.65% -3.88%
VERU Veru Inc. Sell -5.86% 8.33%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NVRO
Assets Removed
Asset Action Perf %
ALGN Sell All -2.57%
Assets Rebalanced
None
2024-10-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 11.77% -0.5%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.2% 3.2%
VCEL Vericel Corporation Buy 12.87% 8.89%
VREX Varex Imaging Corporation Buy 9.49% 10%
NUTX Nutex Health Inc. Buy 9.94% -10.96%
CDMO Avid Bioservices, Inc. Buy 2.48% -1.74%
ALGN Align Technology, Inc. Buy 13.7% -1.68%
HCSG Healthcare Services Group, Inc. Buy 24.37% 0.64%
IOVA Iovance Biotherapeutics, Inc. Buy 23.74% -1.99%
NEOG Neogen Corporation Buy 7.44% 0%
EVH Evolent Health, Inc. Sell -5.65% -0.34%
SMTI Sanara MedTech Inc. Sell -5.86% -2.69%
COLL Collegium Pharmaceutical, Inc. Sell -5.86% -2.71%
CHRS Coherus BioSciences, Inc. Sell -6.63% -2.91%
VERU Veru Inc. Sell -6.14% 4.76%
The percentage of cash held in the portfolio is: 2.14%
New Assets Added
  • NEOG
Assets Removed
Asset Action Perf %
NKTR Sell All -12.41%
Assets Rebalanced
None
2024-10-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 11.39% -2.32%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.16% 4.24%
VCEL Vericel Corporation Buy 12.65% 8.48%
VREX Varex Imaging Corporation Buy 9.25% 8.68%
NKTR Nektar Therapeutics Buy 7.99% -6.21%
NUTX Nutex Health Inc. Buy 10.64% -3.3%
CDMO Avid Bioservices, Inc. Buy 2.42% -2.51%
ALGN Align Technology, Inc. Buy 13.71% -0.29%
HCSG Healthcare Services Group, Inc. Buy 23.89% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 23.89% 0%
EVH Evolent Health, Inc. Sell -5.65% -1.81%
SMTI Sanara MedTech Inc. Sell -5.87% -4.15%
COLL Collegium Pharmaceutical, Inc. Sell -5.77% -2.39%
CHRS Coherus BioSciences, Inc. Sell -6.36% 0%
VERU Veru Inc. Sell -6.36% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • CHRS
  • VERU
  • HCSG
  • IOVA
Assets Removed
Asset Action Perf %
SGMO Sell All 110.31%
Assets Rebalanced
None
2024-10-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 12.01% -4.47%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.05% 3.82%
VCEL Vericel Corporation Buy 13.07% 3.94%
SGMO Sangamo Therapeutics, Inc. Buy 19.43% 54.64%
VREX Varex Imaging Corporation Buy 9.79% 6.69%
NKTR Nektar Therapeutics Buy 8.35% -8.97%
NUTX Nutex Health Inc. Buy 11.61% -2.14%
CDMO Avid Bioservices, Inc. Buy 2.59% -3.47%
ALGN Align Technology, Inc. Buy 15.01% 1.33%
EVH Evolent Health, Inc. Sell -6.2% -3.58%
SMTI Sanara MedTech Inc. Sell -6.1% -0.48%
COLL Collegium Pharmaceutical, Inc. Sell -6.14% -1.14%
The percentage of cash held in the portfolio is: 13.53%
New Assets Added
None
Assets Removed
Asset Action Perf %
ORGO Sell All -9.09%
Assets Rebalanced
None
2024-10-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 11.74% -6.82%
ARDX Ardelyx, Inc. Buy 12.14% -2.98%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.87% 2.94%
VCEL Vericel Corporation Buy 12.74% 1.85%
SGMO Sangamo Therapeutics, Inc. Buy 19.2% 53.61%
VREX Varex Imaging Corporation Buy 9.67% 5.95%
NKTR Nektar Therapeutics Buy 8.5% -6.9%
NUTX Nutex Health Inc. Buy 11.69% -0.97%
CDMO Avid Bioservices, Inc. Buy 2.63% -1.45%
ALGN Align Technology, Inc. Buy 14.74% 0%
EVH Evolent Health, Inc. Sell -5.85% 1.81%
SMTI Sanara MedTech Inc. Sell -6.04% 0%
COLL Collegium Pharmaceutical, Inc. Sell -6.04% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • SMTI
  • COLL
  • ALGN
Assets Removed
None
Assets Rebalanced
None
2024-10-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 11.83% -6.17%
ARDX Ardelyx, Inc. Buy 11.56% -7.62%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.87% 2.89%
VCEL Vericel Corporation Buy 12.57% 0.45%
SGMO Sangamo Therapeutics, Inc. Buy 19.85% 58.76%
VREX Varex Imaging Corporation Buy 9.62% 5.37%
NKTR Nektar Therapeutics Buy 8.88% -2.76%
NUTX Nutex Health Inc. Buy 11.23% -4.88%
CDMO Avid Bioservices, Inc. Buy 2.67% 0%
EVH Evolent Health, Inc. Sell -5.75% 3.41%
The percentage of cash held in the portfolio is: 4.67%
New Assets Added
  • CDMO
Assets Removed
Asset Action Perf %
CUTR Buy All 12%
FATE Buy All 5.61%
ORMP Buy All 0.42%
IRWD Sell All -6.57%
CDXS Sell All -9.73%
Assets Rebalanced
None
2024-10-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.01% -4.23%
ORGO Organogenesis Holdings Inc. Buy 12.92% 0.65%
ARDX Ardelyx, Inc. Buy 12.19% -4.3%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.41% 5.27%
VCEL Vericel Corporation Buy 12.66% -0.62%
CDXS Codexis, Inc. Buy 12.39% -2.65%
SGMO Sangamo Therapeutics, Inc. Buy 15.88% 24.74%
VREX Varex Imaging Corporation Buy 9.64% 3.64%
NKTR Nektar Therapeutics Buy 9.23% -0.69%
NUTX Nutex Health Inc. Buy 12.02% 0%
CUTR Cutera, Inc. Sell -5.54% 6.8%
FATE Fate Therapeutics, Inc. Sell -5.91% 0.62%
ORMP Oramed Pharmaceuticals Inc. Sell -5.9% 0.84%
EVH Evolent Health, Inc. Sell -6% 0.99%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NUTX
Assets Removed
Asset Action Perf %
IRTC Buy All -20.54%
Assets Rebalanced
None
2024-10-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.6% -1.64%
ORGO Organogenesis Holdings Inc. Buy 13.29% 0.97%
ARDX Ardelyx, Inc. Buy 12.72% -2.65%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.82% 5.84%
VCEL Vericel Corporation Buy 12.78% -2.16%
CDXS Codexis, Inc. Buy 12.67% -2.95%
SGMO Sangamo Therapeutics, Inc. Buy 12.25% -6.19%
VREX Varex Imaging Corporation Buy 9.93% 4.13%
NKTR Nektar Therapeutics Buy 9.14% -4.14%
CUTR Cutera, Inc. Sell -5.69% 6.67%
FATE Fate Therapeutics, Inc. Sell -5.98% 1.87%
ORMP Oramed Pharmaceuticals Inc. Sell -6% 1.67%
IRTC iRhythm Technologies, Inc. Sell -6.11% 0.97%
EVH Evolent Health, Inc. Sell -6.22% 0%
The percentage of cash held in the portfolio is: 21.81%
New Assets Added
  • EVH
Assets Removed
Asset Action Perf %
BKD Sell All 3.8%
Assets Rebalanced
None
2024-10-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.05% 4.23%
ORGO Organogenesis Holdings Inc. Buy 12.87% -0.32%
ARDX Ardelyx, Inc. Buy 12.37% -3.48%
BKD Brookdale Senior Living Inc. Buy 14% 9.26%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.79% 7.64%
VCEL Vericel Corporation Buy 12.38% -3.37%
CDXS Codexis, Inc. Buy 12.73% -0.59%
SGMO Sangamo Therapeutics, Inc. Buy 12.41% -3.09%
VREX Varex Imaging Corporation Buy 9.35% 0%
NKTR Nektar Therapeutics Buy 9.35% 0%
CUTR Cutera, Inc. Sell -5.26% 12%
FATE Fate Therapeutics, Inc. Sell -6% -0.31%
ORMP Oramed Pharmaceuticals Inc. Sell -6.01% -0.42%
IRTC iRhythm Technologies, Inc. Sell -6.03% 0.35%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • VREX
  • NKTR
Assets Removed
Asset Action Perf %
AXSM Buy All -7.81%
RDNT Sell All -3.2%
Assets Rebalanced
None
2024-10-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.78% 3.05%
ORGO Organogenesis Holdings Inc. Buy 13.26% 3.9%
ARDX Ardelyx, Inc. Buy 12.52% -1.16%
BKD Brookdale Senior Living Inc. Buy 12.71% 0.33%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.01% 2.69%
VCEL Vericel Corporation Buy 12.63% -0.33%
RDNT RadNet, Inc. Buy 12.69% 0.2%
CDXS Codexis, Inc. Buy 12.66% 0%
SGMO Sangamo Therapeutics, Inc. Buy 12.66% 0%
CUTR Cutera, Inc. Sell -5.44% 8%
FATE Fate Therapeutics, Inc. Sell -5.62% 4.98%
ORMP Oramed Pharmaceuticals Inc. Sell -5.82% 1.67%
IRTC iRhythm Technologies, Inc. Sell -5.74% 4.11%
AXSM Axsome Therapeutics, Inc. Sell -5.97% 0.18%
The percentage of cash held in the portfolio is: 14.66%
New Assets Added
  • CDXS
  • SGMO
Assets Removed
None
Assets Rebalanced
None
2024-10-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.63% 0.7%
ORGO Organogenesis Holdings Inc. Buy 12.94% 0.32%
ARDX Ardelyx, Inc. Buy 12.69% -0.83%
BKD Brookdale Senior Living Inc. Buy 12.8% 0%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.8% 0%
VCEL Vericel Corporation Buy 12.8% 0%
RDNT RadNet, Inc. Buy 12.8% 0%
CUTR Cutera, Inc. Sell -5.66% 5.33%
FATE Fate Therapeutics, Inc. Sell -5.68% 4.98%
ORMP Oramed Pharmaceuticals Inc. Sell -5.95% 0.42%
IRTC iRhythm Technologies, Inc. Sell -5.58% 7.61%
AXSM Axsome Therapeutics, Inc. Sell -5.96% 1.35%
The percentage of cash held in the portfolio is: 40.39%
New Assets Added
  • BKD
  • ARWR
  • VCEL
  • RDNT
Assets Removed
None
Assets Rebalanced
None
2024-10-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.62% 0%
ORGO Organogenesis Holdings Inc. Buy 12.93% -0.32%
ARDX Ardelyx, Inc. Buy 12.87% 0%
CUTR Cutera, Inc. Sell -6.09% -1.33%
FATE Fate Therapeutics, Inc. Sell -5.79% 3.74%
ORMP Oramed Pharmaceuticals Inc. Sell -5.99% 0.42%
IRTC iRhythm Technologies, Inc. Sell -5.53% 8.99%
AXSM Axsome Therapeutics, Inc. Sell -6.15% -1.12%
The percentage of cash held in the portfolio is: 92.12%
New Assets Added
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2024-10-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.44% -1.17%
ORGO Organogenesis Holdings Inc. Buy 12.67% -1.95%
CUTR Cutera, Inc. Sell -5.83% 2.67%
FATE Fate Therapeutics, Inc. Sell -5.48% 8.41%
ORMP Oramed Pharmaceuticals Inc. Sell -6.01% -0.42%
IRTC iRhythm Technologies, Inc. Sell -5.54% 8.5%
AXSM Axsome Therapeutics, Inc. Sell -5.81% 4.05%
The percentage of cash held in the portfolio is: 104.57%
New Assets Added
None
Assets Removed
Asset Action Perf %
BCRX Sell All -6.07%
Assets Rebalanced
None
2024-10-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.69% 0.94%
BCRX BioCryst Pharmaceuticals, Inc. Buy 12.92% 0%
ORGO Organogenesis Holdings Inc. Buy 12.92% 0%
CUTR Cutera, Inc. Sell -5.99% 0%
FATE Fate Therapeutics, Inc. Sell -6.01% -0.31%
ORMP Oramed Pharmaceuticals Inc. Sell -5.89% 1.67%
IRTC iRhythm Technologies, Inc. Sell -6.06% 0%
AXSM Axsome Therapeutics, Inc. Sell -6.06% 0%
The percentage of cash held in the portfolio is: 92.47%
New Assets Added
  • IRTC
  • AXSM
  • BCRX
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-10-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.6% 0%
CUTR Cutera, Inc. Sell -6% 0%
FATE Fate Therapeutics, Inc. Sell -6% 0%
ORMP Oramed Pharmaceuticals Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 106.4%
New Assets Added
  • CUTR
  • FATE
  • ORMP
  • IRWD
Assets Removed
None
Assets Rebalanced
None
2024-09-26 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
VREX Buy All 0.6%
CERS Buy All 16.11%
NVCR Sell All -11.63%
Assets Rebalanced
None
2024-09-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
NVCR NovoCure Limited Buy 18.96% -8.98%
VREX Varex Imaging Corporation Sell -5.63% 5.21%
CERS Cerus Corporation Sell -5.06% 14.69%
The percentage of cash held in the portfolio is: 91.73%
New Assets Added
None
Assets Removed
Asset Action Perf %
MYGN Sell All -1.56%
Assets Rebalanced
None
2024-09-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
NVCR NovoCure Limited Buy 19.09% -8.42%
MYGN Myriad Genetics, Inc. Buy 9.04% -0.15%
VREX Varex Imaging Corporation Sell -5.99% -0.77%
CERS Cerus Corporation Sell -5.01% 15.64%
The percentage of cash held in the portfolio is: 82.87%
New Assets Added
None
Assets Removed
Asset Action Perf %
ESPR Sell All -10.93%
Assets Rebalanced
None
2024-09-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
ESPR Esperion Therapeutics, Inc. Buy 4.92% -4.92%
NVCR NovoCure Limited Buy 19.85% -2.44%
MYGN Myriad Genetics, Inc. Buy 9.33% 5.56%
VREX Varex Imaging Corporation Sell -5.46% 5.73%
CERS Cerus Corporation Sell -4.89% 15.64%
The percentage of cash held in the portfolio is: 76.26%
New Assets Added
None
Assets Removed
Asset Action Perf %
AVXL Buy All 6.46%
PODD Sell All 15.5%
Assets Rebalanced
None
2024-09-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 24.76% 15.22%
ESPR Esperion Therapeutics, Inc. Buy 5.03% -2.73%
NVCR NovoCure Limited Buy 20.3% -0.17%
MYGN Myriad Genetics, Inc. Buy 9.37% 6.04%
AVXL Anavex Life Sciences Corp. Sell -5.54% 7.14%
VREX Varex Imaging Corporation Sell -5.5% 5.04%
CERS Cerus Corporation Sell -5.41% 6.64%
The percentage of cash held in the portfolio is: 56.98%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Buy All 0.59%
Assets Rebalanced
None
2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 24.86% 14.42%
ESPR Esperion Therapeutics, Inc. Buy 5.03% -3.83%
NVCR NovoCure Limited Buy 20.45% -0.5%
MYGN Myriad Genetics, Inc. Buy 9.24% 3.45%
STAA STAAR Surgical Company Sell -6.11% 3.06%
AVXL Anavex Life Sciences Corp. Sell -5.84% 3.06%
VREX Varex Imaging Corporation Sell -5.77% 1.45%
CERS Cerus Corporation Sell -5.72% 2.37%
The percentage of cash held in the portfolio is: 63.86%
New Assets Added
None
Assets Removed
Asset Action Perf %
AADI Sell All 7.43%
TVTX Sell All 48.65%
Assets Rebalanced
None
2024-09-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 11.78% 2.86%
PODD Insulet Corporation Buy 24.83% 14.41%
TVTX Travere Therapeutics, Inc. Buy 7.34% 40.42%
ESPR Esperion Therapeutics, Inc. Buy 5.46% 4.37%
NVCR NovoCure Limited Buy 21.13% 2.88%
MYGN Myriad Genetics, Inc. Buy 9.12% 2.3%
STAA STAAR Surgical Company Sell -6.29% -0.03%
AVXL Anavex Life Sciences Corp. Sell -5.44% 9.69%
VREX Varex Imaging Corporation Sell -5.91% -1.03%
CERS Cerus Corporation Sell -5.74% 1.9%
The percentage of cash held in the portfolio is: 43.73%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDMO Buy All -5.48%
Assets Rebalanced
None
2024-09-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 11.88% 1.14%
PODD Insulet Corporation Buy 25.09% 12.73%
TVTX Travere Therapeutics, Inc. Buy 7.04% 31.25%
ESPR Esperion Therapeutics, Inc. Buy 5.13% -4.37%
NVCR NovoCure Limited Buy 20.22% -3.99%
MYGN Myriad Genetics, Inc. Buy 8.95% -2.15%
CDMO Avid Bioservices, Inc. Sell -6.83% -5.48%
STAA STAAR Surgical Company Sell -5.97% 7.41%
AVXL Anavex Life Sciences Corp. Sell -5.47% 11.39%
VREX Varex Imaging Corporation Sell -5.89% 1.88%
CERS Cerus Corporation Sell -5.8% 3.32%
The percentage of cash held in the portfolio is: 51.67%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGEN Sell All 8.41%
Assets Rebalanced
None
2024-09-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGEN Agenus Inc. Buy 10.83% 3.11%
AADI Aadi Bioscience, Inc. Buy 12.4% 5.14%
PODD Insulet Corporation Buy 24.9% 11.4%
TVTX Travere Therapeutics, Inc. Buy 6.86% 27.5%
ESPR Esperion Therapeutics, Inc. Buy 5.12% -4.92%
NVCR NovoCure Limited Buy 20.18% -4.54%
MYGN Myriad Genetics, Inc. Buy 8.95% -2.56%
CDMO Avid Bioservices, Inc. Sell -6.51% -0.19%
STAA STAAR Surgical Company Sell -6.07% 6.36%
AVXL Anavex Life Sciences Corp. Sell -5.41% 12.76%
VREX Varex Imaging Corporation Sell -5.89% 2.22%
CERS Cerus Corporation Sell -5.85% 2.84%
The percentage of cash held in the portfolio is: 40.49%
New Assets Added
None
Assets Removed
Asset Action Perf %
APLS Sell All -3.75%
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.35% -1.69%
AGEN Agenus Inc. Buy 10.51% -0.18%
AADI Aadi Bioscience, Inc. Buy 12.02% 1.71%
PODD Insulet Corporation Buy 24.81% 10.8%
TVTX Travere Therapeutics, Inc. Buy 7.21% 33.75%
ESPR Esperion Therapeutics, Inc. Buy 5.1% -5.46%
NVCR NovoCure Limited Buy 19.84% -6.37%
MYGN Myriad Genetics, Inc. Buy 9.23% 0.26%
CDMO Avid Bioservices, Inc. Sell -6.46% 0.85%
STAA STAAR Surgical Company Sell -6.05% 6.89%
AVXL Anavex Life Sciences Corp. Sell -5.29% 14.88%
VREX Varex Imaging Corporation Sell -5.86% 2.99%
CERS Cerus Corporation Sell -5.87% 2.84%
The percentage of cash held in the portfolio is: 30.45%
New Assets Added
None
Assets Removed
Asset Action Perf %
CARA Sell All -18.08%
Assets Rebalanced
None
2024-09-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.45% 0.21%
CARA Cara Therapeutics, Inc. Buy 9.43% -9.62%
AGEN Agenus Inc. Buy 9.78% -6.22%
AADI Aadi Bioscience, Inc. Buy 12.11% 3.43%
PODD Insulet Corporation Buy 23.78% 7.2%
TVTX Travere Therapeutics, Inc. Buy 7.16% 33.96%
ESPR Esperion Therapeutics, Inc. Buy 4.96% -7.1%
NVCR NovoCure Limited Buy 19.32% -7.98%
MYGN Myriad Genetics, Inc. Buy 9.17% 0.63%
CDMO Avid Bioservices, Inc. Sell -5.46% 15.41%
STAA STAAR Surgical Company Sell -5.97% 7.17%
AVXL Anavex Life Sciences Corp. Sell -5.39% 12.41%
VREX Varex Imaging Corporation Sell -5.23% 12.56%
CERS Cerus Corporation Sell -5.73% 4.27%
The percentage of cash held in the portfolio is: 21.62%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALDX Sell All -6.49%
Assets Rebalanced
None
2024-09-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.85% 3%
CARA Cara Therapeutics, Inc. Buy 9.89% -6.12%
AGEN Agenus Inc. Buy 9.54% -9.51%
AADI Aadi Bioscience, Inc. Buy 12.37% 4.57%
PODD Insulet Corporation Buy 23.55% 5.05%
TVTX Travere Therapeutics, Inc. Buy 6.18% 14.37%
ESPR Esperion Therapeutics, Inc. Buy 4.87% -9.84%
ALDX Aldeyra Therapeutics, Inc. Buy 20.59% -3.01%
NVCR NovoCure Limited Buy 19.84% -6.48%
MYGN Myriad Genetics, Inc. Buy 9.21% 0%
CDMO Avid Bioservices, Inc. Sell -5.44% 16.54%
STAA STAAR Surgical Company Sell -6.25% 3.86%
AVXL Anavex Life Sciences Corp. Sell -5.45% 12.41%
VREX Varex Imaging Corporation Sell -5.97% 1.28%
CERS Cerus Corporation Sell -5.79% 4.27%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MYGN
Assets Removed
Asset Action Perf %
ORGO Sell All -12.72%
Assets Rebalanced
None
2024-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.3% -1.42%
ORGO Organogenesis Holdings Inc. Buy 9.75% -6.71%
CARA Cara Therapeutics, Inc. Buy 9.78% -6.41%
AGEN Agenus Inc. Buy 9.55% -8.59%
AADI Aadi Bioscience, Inc. Buy 12.06% 2.86%
PODD Insulet Corporation Buy 23.5% 5.72%
TVTX Travere Therapeutics, Inc. Buy 5.54% 3.44%
ESPR Esperion Therapeutics, Inc. Buy 5.03% -6.01%
ALDX Aldeyra Therapeutics, Inc. Buy 21.04% 0%
NVCR NovoCure Limited Buy 21.03% 0%
CDMO Avid Bioservices, Inc. Sell -5.5% 14.93%
STAA STAAR Surgical Company Sell -6.21% 3.61%
AVXL Anavex Life Sciences Corp. Sell -5.83% 5.44%
VREX Varex Imaging Corporation Sell -6.13% -2.31%
CERS Cerus Corporation Sell -5.91% 1.42%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NVCR
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 9.97% -5.21%
ORGO Organogenesis Holdings Inc. Buy 10.03% -4.59%
CARA Cara Therapeutics, Inc. Buy 9.88% -6.12%
AGEN Agenus Inc. Buy 9.33% -11.33%
AADI Aadi Bioscience, Inc. Buy 12.15% 2.86%
PODD Insulet Corporation Buy 23.27% 3.96%
TVTX Travere Therapeutics, Inc. Buy 5.64% 4.69%
ESPR Esperion Therapeutics, Inc. Buy 5.36% -0.55%
ALDX Aldeyra Therapeutics, Inc. Buy 21.19% 0%
CDMO Avid Bioservices, Inc. Sell -5.69% 12.67%
STAA STAAR Surgical Company Sell -6.31% 2.72%
AVXL Anavex Life Sciences Corp. Sell -5.93% 4.42%
VREX Varex Imaging Corporation Sell -6.03% 0%
CERS Cerus Corporation Sell -6.03% 0%
The percentage of cash held in the portfolio is: 23.19%
New Assets Added
  • VREX
  • CERS
  • ALDX
Assets Removed
Asset Action Perf %
CERS Sell All -11.34%
EGRX Sell All -11.35%
Assets Rebalanced
None
2024-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.25% -2.65%
ORGO Organogenesis Holdings Inc. Buy 10.16% -3.53%
CARA Cara Therapeutics, Inc. Buy 10.16% -3.5%
AGEN Agenus Inc. Buy 9.53% -9.51%
CERS Cerus Corporation Buy 10.88% -7.98%
AADI Aadi Bioscience, Inc. Buy 11.75% -0.57%
PODD Insulet Corporation Buy 22.65% 1.11%
EGRX Eagle Pharmaceuticals, Inc. Buy 20.08% -10.38%
TVTX Travere Therapeutics, Inc. Buy 5.4% 0%
ESPR Esperion Therapeutics, Inc. Buy 5.4% 0%
CDMO Avid Bioservices, Inc. Sell -5.99% 8.03%
STAA STAAR Surgical Company Sell -6.49% 0.15%
AVXL Anavex Life Sciences Corp. Sell -5.77% 7.14%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • TVTX
  • ESPR
Assets Removed
Asset Action Perf %
PINC Buy All -4.4%
VERU Buy All -12.35%
ARDX Sell All -11.62%
NEOG Sell All -6.34%
Assets Rebalanced
None
2024-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.64% -3.45%
APLS Apellis Pharmaceuticals, Inc. Buy 9.56% -4.2%
ORGO Organogenesis Holdings Inc. Buy 10.33% 3.53%
CARA Cara Therapeutics, Inc. Buy 10.36% 3.79%
AGEN Agenus Inc. Buy 9.33% -6.58%
CERS Cerus Corporation Buy 10.55% -5.88%
AADI Aadi Bioscience, Inc. Buy 10.76% -4%
NEOG Neogen Corporation Buy 15% -2.15%
PODD Insulet Corporation Buy 21.24% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 21.24% 0%
CDMO Avid Bioservices, Inc. Sell -5.97% 3.4%
STAA STAAR Surgical Company Sell -6.07% 1.42%
PINC Premier, Inc. Sell -6.18% -0.3%
AVXL Anavex Life Sciences Corp. Sell -5.89% 0%
VERU Veru Inc. Sell -5.89% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • AVXL
  • VERU
  • PODD
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.54% -2.35%
APLS Apellis Pharmaceuticals, Inc. Buy 9.71% -0.64%
ORGO Organogenesis Holdings Inc. Buy 10.15% 3.89%
CARA Cara Therapeutics, Inc. Buy 10.23% 4.66%
AGEN Agenus Inc. Buy 10.06% 2.93%
CERS Cerus Corporation Buy 10.7% -2.52%
AADI Aadi Bioscience, Inc. Buy 10.53% -4%
NEOG Neogen Corporation Buy 15% 0%
CDMO Avid Bioservices, Inc. Sell -5.88% 2.74%
STAA STAAR Surgical Company Sell -6.03% 0%
PINC Premier, Inc. Sell -6.03% 0%
The percentage of cash held in the portfolio is: 32.01%
New Assets Added
  • STAA
  • PINC
  • NEOG
Assets Removed
None
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.5% -0.94%
APLS Apellis Pharmaceuticals, Inc. Buy 9.58% -0.05%
ORGO Organogenesis Holdings Inc. Buy 10.27% 7.07%
CARA Cara Therapeutics, Inc. Buy 10.35% 7.87%
AGEN Agenus Inc. Buy 10.29% 7.31%
CERS Cerus Corporation Buy 10.77% 0%
AADI Aadi Bioscience, Inc. Buy 10.77% 0%
CDMO Avid Bioservices, Inc. Sell -5.81% 2.08%
The percentage of cash held in the portfolio is: 34.3%
New Assets Added
  • CERS
  • AADI
Assets Removed
None
Assets Rebalanced
None
2024-08-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.66% -0.31%
APLS Apellis Pharmaceuticals, Inc. Buy 9.75% 0.64%
ORGO Organogenesis Holdings Inc. Buy 10.03% 3.53%
CARA Cara Therapeutics, Inc. Buy 9.84% 1.46%
AGEN Agenus Inc. Buy 10.28% 6.03%
CDMO Avid Bioservices, Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 56.43%
New Assets Added
  • CDMO
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.4% -5.02%
APLS Apellis Pharmaceuticals, Inc. Buy 9.72% -1.79%
ORGO Organogenesis Holdings Inc. Buy 9.61% -2.83%
CARA Cara Therapeutics, Inc. Buy 9.9% 0%
AGEN Agenus Inc. Buy 9.9% 0%
The percentage of cash held in the portfolio is: 51.48%
New Assets Added
  • CARA
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.8% 0%
APLS Apellis Pharmaceuticals, Inc. Buy 9.8% 0%
ORGO Organogenesis Holdings Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 70.6%
New Assets Added
  • ARDX
  • APLS
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-08-21 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
EGRX Buy All 3.38%
Assets Rebalanced
None
2024-08-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Sell -5.84% 4.43%
The percentage of cash held in the portfolio is: 105.84%
New Assets Added
None
Assets Removed
Asset Action Perf %
CYH Sell All -1.57%
Assets Rebalanced
None
2024-08-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 13.02% -2.95%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.34% 12.45%
The percentage of cash held in the portfolio is: 92.32%
New Assets Added
None
Assets Removed
Asset Action Perf %
PODD Buy All -2.48%
Assets Rebalanced
None
2024-08-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 12.44% -7.66%
PODD Insulet Corporation Sell -6.37% 2.34%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.49% 10.34%
The percentage of cash held in the portfolio is: 99.42%
New Assets Added
None
Assets Removed
Asset Action Perf %
RMD Sell All 1.39%
RCM Sell All 7.14%
Assets Rebalanced
None
2024-08-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 11.55% 7.06%
CYH Community Health Systems, Inc. Buy 12.7% -5.3%
RMD ResMed Inc. Buy 14.98% 3.67%
PODD Insulet Corporation Sell -6.35% 2.25%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.61% 8.02%
The percentage of cash held in the portfolio is: 72.73%
New Assets Added
None
Assets Removed
Asset Action Perf %
BKD Sell All -5.42%
FATE Sell All 7.71%
Assets Rebalanced
None
2024-08-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
BKD Brookdale Senior Living Inc. Buy 7.8% -1.06%
FATE Fate Therapeutics, Inc. Buy 9.38% 19.02%
RCM R1 RCM Inc. Buy 11.42% 7.83%
CYH Community Health Systems, Inc. Buy 12.91% -1.96%
RMD ResMed Inc. Buy 15.25% 7.5%
PODD Insulet Corporation Sell -6.42% -0.76%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.81% 2.95%
The percentage of cash held in the portfolio is: 55.48%
New Assets Added
None
Assets Removed
Asset Action Perf %
HQY Sell All -11.82%
HCSG Sell All -6.49%
Assets Rebalanced
None
2024-08-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
BKD Brookdale Senior Living Inc. Buy 7.91% 2.25%
FATE Fate Therapeutics, Inc. Buy 10.6% 37.02%
RCM R1 RCM Inc. Buy 10.27% -1.15%
CYH Community Health Systems, Inc. Buy 13.35% 3.34%
HQY HealthEquity, Inc. Buy 12.52% -3.09%
HCSG Healthcare Services Group, Inc. Buy 3.99% -1.12%
RMD ResMed Inc. Buy 14.27% 2.5%
PODD Insulet Corporation Sell -6.24% 0.31%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.97% -1.69%
The percentage of cash held in the portfolio is: 39.29%
New Assets Added
None
Assets Removed
Asset Action Perf %
OPK Sell All 7.58%
PDSB Sell All 1.14%
Assets Rebalanced
None
2024-07-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 13.34% 8.33%
PDSB PDS Biotechnology Corporation Buy 10.08% -1.7%
BKD Brookdale Senior Living Inc. Buy 8.08% 3.44%
FATE Fate Therapeutics, Inc. Buy 10.3% 31.88%
RCM R1 RCM Inc. Buy 10.39% -1%
CYH Community Health Systems, Inc. Buy 13.23% 1.38%
HQY HealthEquity, Inc. Buy 12.63% -3.16%
HCSG Healthcare Services Group, Inc. Buy 4.05% -0.43%
RMD ResMed Inc. Buy 14.06% 0%
PODD Insulet Corporation Sell -6.28% 0.6%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.93% 0%
The percentage of cash held in the portfolio is: 16.06%
New Assets Added
  • EGRX
  • RMD
Assets Removed
Asset Action Perf %
SMTI Sell All -8.69%
CLDX Sell All -12.36%
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings